Avidity Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
44.00
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
6
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.93
|
-0.82
|
0.11
|
11.83%
|
|
2022-06-30
|
-0.75
|
-0.92
|
-0.17
|
-22.67%
|
|
2022-03-31
|
-0.80
|
-0.71
|
0.09
|
11.25%
|
|
2021-12-31
|
-0.70
|
-0.82
|
-0.12
|
-17.14%
|
|
2021-09-30
|
-0.68
|
-0.68
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.71
|
-0.70
|
0.01
|
1.41%
|
|
2021-03-31
|
-0.56
|
-0.64
|
-0.08
|
-14.29%
|
|
2020-12-31
|
-0.34
|
-0.43
|
-0.09
|
-26.47%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.45
|
|
2021-12-31
|
-2.84
|
|
2020-12-31
|
-2.85
|
|
2013-12-31
|
-0.11
|